Balchem (BCPC) revenue breakdown
By segment, Human Nutrition and Health is the largest at 64% of fiscal 2025 revenue, growing 9% a year over 9 years.
By product, Product Sales Revenue is the largest at 100% of fiscal 2025 revenue, growing 8% a year over 9 years.
Revenue by segment
Fiscal years, as Balchem reports them in its 10-K filings; fiscal 2025 total $1.0B.
| Segments | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Human Nutrition and Health | $297M | $316M | $341M | $347M | $400M | $443M | $527M | $551M | $600M | $659M | 64% |
| Animal Nutrition and Health | $161M | $158M | $176M | $178M | $192M | $227M | $262M | $238M | $215M | $231M | 22% |
| Specialty Products | $70M | $73M | $76M | $92M | $104M | $117M | $131M | $126M | $133M | $141M | 14% |
Revenue by product
Fiscal years, as Balchem reports them in its 10-K filings; fiscal 2025 total $1.0B.
| Products | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Product Sales Revenue | $505M | $564M | $608M | $610M | $666M | $795M | $939M | $920M | $952M | $1.0B | 100% |
| Royalty Revenue | $3M | $5M | $4M | $4M | $4M | $5M | $3M | $2M | $2M | $2M | 0% |
| Co-manufacturing | $39M | $20M | $24M | $24M | $29M | — | — | — | — | — | — |
| Bill and Hold | $3M | $4M | $5M | $3M | — | — | — | — | — | — | — |
| Consignment | $2M | $2M | $2M | $2M | $3M | — | — | — | — | — | — |
| Bill and Hold | — | — | — | — | $1M | — | — | — | — | — | — |
Revenue by region
Fiscal years, as Balchem reports them in its 10-K filings; fiscal 2025 total $1.0B.
| Regions | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $421M | $461M | $483M | $475M | $516M | $585M | $682M | $690M | $723M | $759M | 73% |
| Foreign Countries | $132M | $134M | $161M | $169M | $187M | $214M | $260M | $233M | $230M | $278M | 27% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for BCPC.
Open BCPC in InvestinglyQuestions
Where does Balchem make its money?
In fiscal 2025, by segment: Human Nutrition and Health $659M, Animal Nutrition and Health $231M, Specialty Products $141M.
From Balchem's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.